Sjuts Dustin S
Officer at Revance Therapeutics, Inc.
- Sold, on record
- $1.6M
- Dollars the filings state
- Form 4 sales
- 4
- Latest Mar 18, 2024
- Form 144 notices
- 4
- Proposed sales
- Companies
- 1
- Filed as an executive or holder
Companies
- Revance Therapeutics, Inc.Officer
Sales by reason
Form 4 sales per month, last 12 months.
Timeline
- 1 Form 144 notice Revance Therapeutics, Inc.NoticeMar 8, 2023 2023
Filed to sell 23,000 shares ($759k)
Sjuts Dustin S, Officer
No 10b5-1 planFirst sale on recordFiling
- 2 Form 4 sale Revance Therapeutics, Inc.Plan not statedMar 9, 2023 +1 day
Sold 21,508 shares at $31.59 ($679k)
Sjuts Dustin S, President
Sold 14.8% of holdings ($4.6M position)123,934 shares leftFirst sale on recordFollows a Form 144Filing
- 3 Form 144 notice Revance Therapeutics, Inc.NoticeMay 12, 2023 +64 days
Filed to sell 22,000 shares ($735k)
Sjuts Dustin S, Officer
No 10b5-1 planFiling
- 4 Form 4 sale Revance Therapeutics, Inc.No planMay 15, 2023 +3 days
Sold 21,015 shares at $34.55 ($726k)
Sjuts Dustin S, President
No 10b5-1 planSold 12.1% of holdings ($6M position)152,347 shares leftFollows a Form 144Filing
- 5 Form 144 notice Revance Therapeutics, Inc.NoticeJun 9, 2023 +25 days
Filed to sell 5,000 shares ($154k)
Sjuts Dustin S, Officer
10b5-1 planFiling
- 6 Form 4 sale Revance Therapeutics, Inc.RoutineJun 9, 2023 same day
Sold 5,000 shares at $30.82 ($154k)
Sjuts Dustin S, President
10b5-1 planSold 3.3% of holdings ($4.7M position)147,347 shares leftFollows a Form 144Filing
- 7 Form 144 notice Revance Therapeutics, Inc.NoticeMar 18, 2024 +283 days
Filed to sell 9,500 shares ($53k)
Sjuts Dustin S, Officer
No 10b5-1 plan0.5x usual sizeFiling
- 8 Form 4 sale Revance Therapeutics, Inc.No planMar 18, 2024 same day
Sold 9,211 shares at $5.04 ($46k)
Sjuts Dustin S, President
No 10b5-1 planSold 5.2% of holdings ($891k position)167,550 shares left0.4x usual sizeFollows a Form 144Filing
Every transaction
Loading transactions…
Sales and notices (8)
| Source | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Mar 18, 2024 | Mar 19, 2024 | Revance Therapeutics, Inc. | President | Form 4 sale | 9,211 | $46k | 5.2% | No plan | SEC |
| Mar 18, 2024 | Mar 18, 2024 | Revance Therapeutics, Inc. | Officer | Form 144 notice | 9,500 | $53k | Notice | SEC | |
| Jun 9, 2023 | Jun 13, 2023 | Revance Therapeutics, Inc. | President | Form 4 sale | 5,000 | $154k | 3.3% | Routine | SEC |
| Jun 9, 2023 | Jun 9, 2023 | Revance Therapeutics, Inc. | Officer | Form 144 notice | 5,000 | $154k | Notice | SEC | |
| May 15, 2023 | May 16, 2023 | Revance Therapeutics, Inc. | President | Form 4 sale | 21,015 | $726k | 12.1% | No plan | SEC |
| May 12, 2023 | May 12, 2023 | Revance Therapeutics, Inc. | Officer | Form 144 notice | 22,000 | $735k | Notice | SEC | |
| Mar 9, 2023 | Mar 9, 2023 | Revance Therapeutics, Inc. | President | Form 4 sale | 21,508 | $679k | 14.8% | Plan not stated | SEC |
| Mar 8, 2023 | Mar 8, 2023 | Revance Therapeutics, Inc. | Officer | Form 144 notice | 23,000 | $759k | Notice | SEC |